Literature DB >> 19765022

Occurrence of macrolide-resistant Mycoplasma pneumoniae strains in Germany.

R Dumke1, H von Baum, P C Lück, E Jacobs.   

Abstract

In a total of 167 respiratory tract specimens from adult outpatients with confirmed Mycoplasma pneumoniae pneumonia, sampled between 2003 and 2008, and a further 99 isolates obtained from patients between 1991 and 2009 in Germany, M. pneumoniae was tested for macrolide resistance. Using PCR, real-time PCR and sequencing of the 23S rRNA gene, 1.2% of M. pneumoniae in the respiratory tract samples and 3.0% of the isolates were found to be resistant. The results indicate a limited but not negligible importance of macrolide-resistant M. pneumoniae in the population investigated, which requires the monitoring of macrolide susceptibility of isolates or the testing of respiratory samples by molecular methods.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19765022     DOI: 10.1111/j.1469-0691.2009.02968.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  51 in total

1.  Antibiotic sensitivity of 40 Mycoplasma pneumoniae isolates and molecular analysis of macrolide-resistant isolates from Beijing, China.

Authors:  Fei Zhao; Min Lv; Xiaoxia Tao; Hui Huang; Binghua Zhang; Zhen Zhang; Jianzhong Zhang
Journal:  Antimicrob Agents Chemother       Date:  2011-11-21       Impact factor: 5.191

2.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

3.  In vitro subminimum inhibitory concentrations of macrolide antibiotics induce macrolide resistance in Mycoplasma pneumoniae.

Authors:  G Ou; Y Liu; Y Tang; X You; Y Zeng; J Xiao; L Chen; M Yu; M Wang; C Zhu
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

4.  First report of macrolide resistance in a Mycoplasma pneumoniae isolate causing community-acquired pneumonia in Spain.

Authors:  Juan de Dios Caballero; Rosa del Campo; María Del Carmen Mafé; María Gálvez; Mario Rodríguez-Domínguez; Rafael Cantón; María Antonia Meseguer; José Manuel Hermida
Journal:  Antimicrob Agents Chemother       Date:  2013-12-02       Impact factor: 5.191

5.  Long-Term Low Rate of Macrolide-Resistant Mycoplasma pneumoniae Strains in Germany.

Authors:  Roger Dumke; Thomas Ziegler
Journal:  Antimicrob Agents Chemother       Date:  2019-04-25       Impact factor: 5.191

Review 6.  Mycoplasma pneumoniae from the Respiratory Tract and Beyond.

Authors:  Ken B Waites; Li Xiao; Yang Liu; Mitchell F Balish; T Prescott Atkinson
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

7.  Multilocus variable-number tandem-repeat analysis-confirmed emergence of a macrolide resistance-associated mutation in Mycoplasma pneumoniae during macrolide therapy for interstitial pneumonia in an immunocompromised child.

Authors:  Sébastien Hantz; Fabien Garnier; Olivia Peuchant; Céline Menetrey; Alain Charron; Marie-Cécile Ploy; Cécile Bébéar; Sabine Pereyre
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

8.  Low rate of macrolide resistance in Mycoplasma pneumoniae strains in Germany between 2009 and 2012.

Authors:  Roger Dumke; Christian Lück; Enno Jacobs
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

9.  Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.

Authors:  Yasuhiro Kawai; Naoyuki Miyashita; Mika Kubo; Hiroto Akaike; Atsushi Kato; Yoko Nishizawa; Aki Saito; Eisuke Kondo; Hideto Teranishi; Satoko Ogita; Takaaki Tanaka; Kozo Kawasaki; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Antimicrob Agents Chemother       Date:  2013-03-04       Impact factor: 5.191

10.  Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients.

Authors:  Yasuhiro Kawai; Naoyuki Miyashita; Mika Kubo; Hiroto Akaike; Atsushi Kato; Yoko Nishizawa; Aki Saito; Eisuke Kondo; Hideto Teranishi; Tokio Wakabayashi; Satoko Ogita; Takaaki Tanaka; Kozo Kawasaki; Takashi Nakano; Kihei Terada; Kazunobu Ouchi
Journal:  Antimicrob Agents Chemother       Date:  2013-05-28       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.